We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
AUM
$2.15B
AUM Growth
+$655M
Cap. Flow
+$252M
Cap. Flow %
11.74%
Top 10 Hldgs %
79.61%
Holding
129
New
20
Increased
47
Reduced
20
Closed
23

Sector Composition

Rank Sector Weight
1 Miscellaneous 84.5%
2 Healthcare 12.28%
3 Energy 1.1%
4 Industrials 1.04%
5 Technology 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITCI
51
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.26M 0.11%
30,883
+12,346
+67% +$928K
AVTR icon
52
Avantor
AVTR
$10.1B
$2.19M 0.1%
84,678
+34,102
+67% +$837K
EQLS
53
DELISTED
Simplify Market Neutral Equity Long/Short ETF
EQLS
$2.05M 0.1%
94,670
-27,052
-22% -$611K
EXAS
54
DELISTED
Exact Sciences
EXAS
$1.99M 0.09%
29,277
+11,800
+68% +$666K
GBTC icon
55
Grayscale Bitcoin Trust
GBTC
$12B
$1.72M 0.08%
34,152
-9,981
-23% -$486K
BTC
56
Grayscale Bitcoin Mini Trust ETF
BTC
$4.23B
$1.61M 0.08%
+57,246
New +$1.53M
ABT icon
57
Abbott
ABT
$187B
$1.61M 0.07%
14,083
+5,664
+67% +$621K
KURA icon
58
Kura Oncology
KURA
$1.18B
$1.56M 0.07%
80,000
QIS icon
59
Simplify Multi-QIS Alternative ETF
QIS
$43.2M
$1.53M 0.07%
62,035
+2,700
+5% +$67.4K
RITM icon
60
Rithm Capital
RITM
$5.63B
$1.5M 0.07%
134,800
+99,000
+277% +$1.13M
KYMR icon
61
Kymera Therapeutics
KYMR
$9.76B
$1.44M 0.07%
30,515
CTA icon
62
Simplify Managed Futures Strategy ETF
CTA
$1.61B
$1.41M 0.07%
54,118
-25,765
-32% -$676K
AGNC icon
63
AGNC Investment
AGNC
$12.6B
$1.38M 0.06%
132,000
-48,000
-27% -$488K
ARGX icon
64
argenx
ARGX
$64.6B
$1.31M 0.06%
2,419
+944
+64% +$477K
THC icon
65
Tenet Healthcare
THC
$21.3B
$1.31M 0.06%
7,872
+3,186
+68% +$482K
FULC icon
66
Fulcrum Therapeutics
FULC
$294M
$1.25M 0.06%
351,314
-323,518
-48% -$2.4M
SPQ
67
DELISTED
Simplify US Equity PLUS QIS ETF
SPQ
$1.22M 0.06%
39,218
-6,760
-15% -$204K
NVDA icon
68
NVIDIA
NVDA
$5.56T
$1.18M 0.06%
9,734
IAU icon
69
iShares Gold Trust
IAU
$65.8B
$1.1M 0.05%
22,085
-3,807
-15% -$178K
BNTC icon
70
Benitec Biopharma
BNTC
$436M
$1.07M 0.05%
116,535
+65,319
+128% +$584K
ACHV icon
71
Achieve Life Sciences
ACHV
$874M
$1.03M 0.05%
217,845
MAC icon
72
PUT
Macerich
MAC
$6.59B
$1M 0.05%
+55,000
New +$867K
COO icon
73
Cooper Companies
COO
$13.6B
$978K 0.05%
8,868
-11,470
-56% -$1.12M
HCA icon
74
HCA Healthcare
HCA
$87.7B
$956K 0.04%
2,351
+944
+67% +$346K
ESTA icon
75
Establishment Labs
ESTA
$2.21B
$936K 0.04%
21,639
+8,732
+68% +$380K

Similar funds

Simplify Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Simplify Asset Management held 129 positions worth $2.15B, up 44% from $1.49B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Simplify Asset Management deployed $252M of net new capital in Q3 2024, opening 20 new positions and adding to 47 existing holdings. Its largest new stake was Simplify National Muni Bond ETF: 3,126,710 shares worth $78.8M.

By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, down from 85% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Simplify High Yield ETF, an estimated $63M trimmed.

  • Simplify Asset Management's largest Q3 2024 buy was Simplify National Muni Bond ETF: 3,126,710 shares worth $78.8M.
  • Simplify Asset Management added most to Simplify Intermediate Term Treasury Futures Strategy ETF in Q3 2024, an estimated $53.8M increase.
  • Simplify Asset Management's biggest Q3 2024 reduction was Simplify High Yield ETF, cutting an estimated $63M.
  • Simplify Asset Management fully exited Merck in Q3 2024, selling an estimated $6.35M.
  • Simplify Asset Management's ten largest holdings make up 80% of its $2.15B portfolio in Q3 2024.
  • Simplify Asset Management opened 20 new positions and closed 23 in Q3 2024.
  • Simplify Asset Management's portfolio value rose 44% quarter-over-quarter to $2.15B.

Based on Simplify Asset Management's 13F filing for Q3 2024, filed 6 Nov 2024.